by Tamar Kahn | Business Day | 21 November 2025 | Nov 24, 2025 | Archive, November 2025
Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Tamar Kahn | Business Day | 21 November 2025 | Nov 21, 2025 | Archive, November 2025
China's HIV prevention funding of $3.49 million aims to support South Africa's young people and drug users for better health outcomes.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Chris Bateman | Financial Mail | 20 November 2025 | Nov 20, 2025 | Archive, November 2025
A pioneering public-private healthcare partnership cuts backlogs and addresses inefficiencies in surgery and patient care in KZN.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Jacqueline Mackenzie | Business Day | 20 November 2025 | Nov 20, 2025 | Archive, November 2025
Life Healthcare share price falls 9% due to R2.9bn adjustment linked to the Piramal liability affecting investor sentiment.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Nancy Lapid | Reuters | 19 November 2025 | Nov 19, 2025 | Archive, November 2025
Delve into the dramatic rise of childhood hypertension and its implications for future health outcomes for young people globally.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Tamar Kahn | Business Day | 19 November 2025 | Nov 19, 2025 | Archive, November 2025
Uncover the details of the Hetero price collusion probe as the Competition Commission examines key drug procurement allegations.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions